Gene mutation leads to poorly understood birth defects

Scientists have identified genetic mutations that appear to be a key culprit behind a suite of birth defects called ciliopathies, which affect an estimated 1 in 1,000 births. In a paper published online this week in Nature Genetics, a team of researchers led by The University of Texas at Austin’s John Wallingford reveals that these mutations prevent certain proteins from working together to smooth the way for cells to communicate with one another.

Credit: John Wallingford

Birth defects from genetic disorders of the cilia — tentacle-like structures in cells that coordinate cell-to-cell communication in healthy people — are varied, ranging from oral-facial-digital syndrome, which can cause extra toes, misshapen teeth, an abnormal tongue and other defects, to short rib polydactyly syndrome, a lethal birth defect that causes every organ in the body to be defective.

“For cells to talk to each other, functioning cilia are needed,” says Wallingford, a professor in the Department of Molecular Biosciences. “We identified a group of proteins that form part of the base that cilia need in order to function. If that base is defective, it can cause serious birth defects that are frequently lethal.”

The new research pinpoints how three proteins work together to form a base that allows cilia to carry critical cell-to-cell communications. Wallingford and his colleagues discovered that, much the way that cellphone towers provide a base for the antennas that assist with communication, these proteins together construct a base that anchors the cilia. Disturbances in the little-known group of proteins, which the researchers called CPLANE, led to disturbed cell communication and observable ciliopathy in mouse models. The team also asked human geneticists to screen for the genes among their patients with similar birth defects and found that mutations in the same genes resulted in ciliopathies in humans.

Wallingford points out that the research is important, given that ciliopathies are more widespread than most people realize. Polycystic kidney disease, for example, which causes the abnormal growth of cysts on kidneys, is a disorder arising from defective cilia and afflicts about 600,000 people in the U.S.

“If you lump ciliopathies, the prevalence is high, and they will become one of the more common congenital diseases,” says Wallingford. “Birth defects are an underappreciated problem, and we have little understanding of their genetic underpinnings despite their prevalence, not to mention their environmental underpinnings.”

This research was funded by the National Institutes of Health and the Howard Hughes Medical Institute.

The ciliopathy-associated CPLANE proteins direct basal body recruitment of intraflagellar transport machinery. Michinori Toriyama, Chanjae Lee, S Paige Taylor, Ivan Duran, Daniel H Cohn, Ange-Line Bruel, Jacqueline M Tabler, Kevin Drew, Marcus R Kelly, Sukyoung Kim, Tae Joo Park, Daniella Braun, Ghislaine Pierquin, Armand Biver, Kerstin Wagner, Anne Malfroot, Inusha Panigrahi, Brunella Franco, Hadeel Adel Al-lami, Yvonne Yeung, Yeon Ja Choi, University of Washington Center for Mendelian Genomics, Yannis Duffourd, Laurence Faivre, Jean-Baptiste Rivière, Jiang Chen, Karen J Liu, Edward M Marcotte, Friedhelm Hildebrandt, Christel Thauvin-Robinet, Deborah Krakow, Peter K Jackson & John B Wallingford. Nature Genetics. DOI:10.1038/ng.3558. Published online 09 May 2016.

Contact our news editors

For any corrections of factual information, or to contact our editorial team, please see our contact page.

Please note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms of use.

Copyright Medical News Today: Excluding email/sharing services explicitly offered on this website, material published on Medical News Today may not be reproduced, or distributed without the prior written permission of Medilexicon International Ltd. Please contact us for further details.

Be the first to comment

Leave a Reply

Your email address will not be published.